There has never been a Lipitor recall over the statin’s potential association with Type 2 diabetes. However, hundreds of product liability lawsuits have been filed by women who allegedly developed the disease due to their use of the cholesterol-lowering medication.
Lipitor, which is currently marketed by Pfizer, Inc., works by reducing the amount of bad (LDL) cholesterol made by the liver. It also raises levels of good cholesterol (HDL). Before it lost patent protection in 2011, Lipitor was one of the top-selling drugs in the world, generating more than $125 billion in sales
Despite its popularity, Lipitor has been linked to a number of serious side effects, including:
While there has never been a Lipitor recall issued due to these adverse events, a growing number of plaintiffs have filed lawsuits over the drug’s alleged connection with Type 2 diabetes. If you are interested in filing such a claim, Bernstein Liebhard LLP can help. To learn more, please contact our office by calling (888) 994-5118.
In 2012, the U.S. Food & Drug Administration (FDA) ordered the manufacturers of Lipitor and other statins to add new information to the drugs’ labels regarding their potential effects on blood glucose levels. The FDA acted after a study published in JAMA: Internal Medicine suggested that post-menopausal women who took Lipitor or other statins faced a 48 percent increased risk for developing Type 2 diabetes compared to those who did not.
Since then, hundreds of Lipitor lawsuits have been filed on behalf of women who allegedly developed Type 2 diabetes due to their use of Lipitor. Federally-filed cases are currently undergoing coordinated pretrial proceedings in the U.S. District Court, District of South Carolina. Lipitor diabetes plaintiffs claim that Pfizer has failed to provide adequate warnings regarding the drug’s risks, even in the wake of the FDA’s 2012 mandate.
It’s not clear why statins might contribute to the development of diabetes. However, some researchers theorize that these drugs can impair the function of special cells in the pancreas that store and release insulin. There is also evidence that Lipitor and other statins can decrease the body’s sensitivity to insulin.
In 2013, Pfizer, Inc. recalled certain lot of Lipitor 40mg because of reports describing an uncharacteristic odor. The odor was related to the bottles used to package the medication. According to Pfizer, a medical assessment determined that the odor was not likely to cause adverse health consequences in patients taking the drug. However, consumers have been asked to return their Lipitor 40mg if they do notice an uncharacteristic odor.
Even though there has not been a Lipitor recall for Type 2 diabetes, you might be eligible to file a lawsuit if you developed this disease while using the statin medication. To arrange for a free review of your case, please contact Bernstein Liebhard LLP by calling (888) 994-5118.
Get the latest news and litigation updates about this case by following us on Facebook. Click the "Like" button below.